Aptus Announces Positive Initial Data from ANCHOR Post-Market Registry by longitudeadmin | Oct 8, 2013 | Portfolio News
Amarin Announces Enrollment of the REDUCE-IT Cardiovascular Outcomes Study Surpasses 6,000 Patients by longitudeadmin | Sep 25, 2013 | Portfolio News
BioWorld Today – Dopamine Road: Civitas’ $38M To Fill in Parkinson’s ‘Potholes’ by longitudeadmin | Sep 12, 2013 | Portfolio News
Civitas Therapeutics Initiates Phase 2b Clinical Study of CVT-301, inhaled L-dopa for Parkinson’s Disease by longitudeadmin | Sep 5, 2013 | Portfolio News
